Clinical Trial

Evaluation of Dyslipidemia Management After Statin and Ezetimibe Complex Treatment

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
This study is a large-scale, prospective, multi-site, and non-interventional observational study to observe the change and safety of dyslipidemia management status when administering statin+etimib complex drugs in patients with dyslipidemia.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2022-11-07; most recent amendment 2025-08-22.
Status change: Recruiting → Active, Not Recruiting 2024-07-01
Trial Details
NCT Number NCT05614765
Lead Sponsor Daewoong Pharmaceutical Co. LTD.
Conditions Dyslipidemias
Enrollment 18,000 participants
Start Date 2022-07-08
Primary Completion 2023-12-31 (estimated)
Study Completion 2025-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-08-24